Synucure therapeutics Headquarters & Office Locations

Synucure therapeutics (Private) is headquartered in Montreal, Quebec, Canada. Founded in 2021, the company operates across 1 countries with approximately 6 employees worldwide.

Where is Synucure therapeutics's main office?

Synucure therapeutics's main headquarters office is located at Montréal, Quebec, CAN, Montreal, Quebec . This serves as the company's primary corporate address and is home to its executive leadership team.

Synucure therapeutics regional offices

Beyond its headquarters in Montreal, Synucure therapeutics maintains 2 offices across 1 countries. Regional offices span 1 countries.

Synucure therapeutics contact information

The main switchboard for Synucure therapeutics headquarters can be reached at —. For investor relations, visit synucure.com/investor-relations.

What does Synucure therapeutics do?

Synucure Therapeutics inc. is a Canadian biotechnology company conducting research in brain degenerative disorders. Synucure was founded in 2021 with the key objective to pursue the promising and robust pre-clinical work of Dr. Francesca Cicchetti on a repurposed drug called Cysteamine which demonstrated, in various animal and cell models, that the drug could prevent and/or reverse a number of features related to Parkinson’s Disease (PD). Her research on the potential benefits of Cysteamine in neurodegenerative disorders was initiated 20 years ago. In addition to the promising role of Cysteamine as a Disease Modifying Therapy (DMT) in Parkinson, Dr. Cicchetti and her colleagues conducted research on patented blood biomarkers, of which the main objective is to provide clinicians with a more precise diagnostic and stratification tool for the disease using a simple blood test. If you need more information, please contact us at [email protected]